In a recently published study, surveys of transgender individuals on hormone therapy provide insight into the self-reported effects of medication where previous thinking was only speculative. Still, controlled studies are required to avoid overinterpreting the clinical significance of specific findings in the context of what might be expected in the general population.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Weinand, J. D. & Safer, J. D. Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals. J. Clin. Transl Endocrinol. 2, 55–60 (2015).
Safer, J. D. & Tangpricha, V. Care of the transgender patient. Ann. Intern. Med. 171, ITC1–ITC16 (2019).
Wierckx, K. et al. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European Network for the Investigation of Gender Incongruence. J. Sex Med. 11, 1999–2011 (2014).
Bisson, J. R., Chan, K. J. & Safer, J. D. Prolactin levels do not rise among transgender women treated with estradiol and spironolactone. Endocr. Pract. 24, 646–651 (2018).
Chan, K. J. et al. Estrogen levels do not rise with testosterone treatment for transgender men. Endocr. Pract. 24, 329–333 (2018).
Hembree, W. C. et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 102, 3869–3903 (2017).
Coleman, E. et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int. J. Transgend. 13, 165–232 (2012).
van Dijk, D. et al. Explorative prospective evaluation of short-term subjective effects of hormonal treatment in trans people – results from the European Network for the Investigation of Gender Incongruence. J. Sex. Med. 16, 1297–1309 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.D.S. served on an advisory panel for Endo Pharmaceuticals in June 2018.
Rights and permissions
About this article
Cite this article
Safer, J.D. Advancing knowledge of transgender medical intervention effects. Nat Rev Urol 16, 642–643 (2019). https://doi.org/10.1038/s41585-019-0222-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-019-0222-2